Sichuan Kelun Pharmaceutical Co Ltd
Sichuan Kelun Pharmaceutical's GHG Emissions Data Preview
In 2024, Sichuan Kelun Pharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Sichuan Kelun Pharmaceutical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  b | 0000000 |
Verified Sources Behind Sichuan Kelun Pharmaceutical’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sichuan Kelun Pharmaceutical’s data sources below and access millions more through our Disclosure Search.
Insights into Sichuan Kelun Pharmaceutical's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Sichuan Kelun Pharmaceutical amounted to 2,845,549.25 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Sichuan Kelun Pharmaceutical increased by 7%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Sichuan Kelun Pharmaceutical's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Sichuan Kelun Pharmaceutical's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Sichuan Kelun Pharmaceutical were 2,361,763.17 metric tons of CO₂ equivalent (tCO₂e). a
Has Sichuan Kelun Pharmaceutical reduced its Scope 1 emissions over time?
Since 2021, Sichuan Kelun Pharmaceutical's Scope 1 emissions have increased by 14.22%, reflecting a rising long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2023), Sichuan Kelun Pharmaceutical's Scope 1 emissions increased by 7.81%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
What are Sichuan Kelun Pharmaceutical's Scope 2 emissions?
In 2024, Sichuan Kelun Pharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 483,786.08 tCO₂e without specifying the calculation method. a
Has Sichuan Kelun Pharmaceutical reduced its Scope 2 emissions over time?
Since 2021, Sichuan Kelun Pharmaceutical's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 92.28%, reflecting a rising long-term trend in Scope 2 emissions over time. a b
Compared to the previous year (2023), Sichuan Kelun Pharmaceutical's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Sichuan Kelun Pharmaceutical 's emissions have plateaued with no significant change in its energy consumption footprint. a
What methodology does Sichuan Kelun Pharmaceutical use for Scope 2 reporting?
In 2024, Sichuan Kelun Pharmaceutical reported its Scope 2 emissions using an unspecified methodology. a
Sichuan Kelun Pharmaceutical's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Sichuan Kelun Pharmaceutical’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Sichuan Kelun Pharmaceutical reported Scope 1 greenhouse gas (GHG) emissions of 2,361,763.17 tCO₂e and total revenues of USD 2,989 millions. This translates into an emissions intensity of 790.21 tCO₂e per millions USD. a
Sichuan Kelun Pharmaceutical's Scope 1 Emissions Intensity Compared to Peers
How does Sichuan Kelun Pharmaceutical's GHG emissions intensity compare to its peers?
In 2024, Sichuan Kelun Pharmaceutical reported a Scope 1 emissions intensity of 790.21 tCO₂e per millions USD. Compared to the peer group median of 11.16 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Sichuan Kelun Pharmaceutical rank on GHG emissions intensity within its industry?
In 2024, Sichuan Kelun Pharmaceutical ranked 25 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Sichuan Kelun Pharmaceutical among the least efficient performers, with one of the highest emissions intensities in its sector. a